EQT invests in SHL Medical, a world-leading provider of drug delivery solutions
· EQT acquires minority stake in SHL Medical, a world-leading manufacturer of advanced drug delivery systems such as autoinjectors · SHL is a pioneer and technology frontrunner in the self-injection industry, promoting well-being for all by allowing patients to safely self-administer medications at home · EQT will support SHL and the management team in its next phase of growth and innovation by leveraging EQT’s healthcare expertise, local angles and digital capabilities The EQT VIII Fund (“EQT”) today announced that it has entered into an agreement to acquire a minority stake